Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancerKenichi Sugihara, Toshiaki Watanabe, Kei Muro et al.|International Journal of Clinical Oncology|2017Cited by 2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerYojiro Hashiguchi, Kei Muro, Yutaka Saitō et al.|International Journal of Clinical Oncology|2019Cited by 2k
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studiesYoshiaki Nakamura, Takayuki Yoshino, Yasuyuki Kawamoto et al.|Nature Medicine|2020Cited by 366
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)Hideyuki Ishida, Osamu Tsuruta, Kohji Tanakaya et al.|Journal of the Anus Rectum and Colon|2018Cited by 47
Phase <scp>II</scp> trial of aflibercept with <scp>FOLFIRI</scp> as a second‐line treatment for Japanese patients with metastatic colorectal cancerTadamichi Denda, Takayuki Yoshino, Daisuke Sakai et al.|Cancer Science|2019Cited by 39